Profile
Joseph de Angelo is the founder of Apex Bioscience, Inc. founded in 1993.
He is currently a Director at ApoLife, Inc. Mr. de Angelo's former position was as Chief Development Officer at Curacyte AG from 2009 to 2014.
He received his undergraduate degree from Massachusetts Institute of Technology in 1974 and his graduate degree from the same institution in 1978.
Joseph de Angelo active positions
| Companies | Position | Start |
|---|---|---|
ApoLife, Inc.
 ApoLife, Inc. Miscellaneous Commercial ServicesCommercial Services ApoLife, Inc. provides screening and lab services. James S. Kuo has been the CEO of the American company since 2012. | Director/Board Member | - |
Former positions of Joseph de Angelo
| Companies | Position | End |
|---|---|---|
Curacyte AG
 Curacyte AG Miscellaneous Commercial ServicesCommercial Services Curacyte AG develops and markets biopharmaceutical solutions. The firm specializes in the development of new therapeutics for acute and critical care applications. Its focus areas cover applications in hematology, antithrombosism, and oncology. Its pipeline and development portfolio encompasses technologies, such as hemoximers, distributive shock, cardiogenic shock, plasmin and plasma kallikrei, matriptase, and high-dose interleukin-2 therapy. The company was founded in February 2000 and is headquartered in Munich, Germany. | Corporate Officer/Principal | 01/03/2014 |
Apex Bioscience, Inc.
 Apex Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Apex Bioscience, Inc. develops patented products based upon hemoglobin and nitric oxide technologies. The company was founded by Joseph de Angelo on June 17, 1993 and is headquartered in Chapel Hill, NC. | Founder | 31/05/2012 |
Training of Joseph de Angelo
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Curacyte AG
Curacyte AG Miscellaneous Commercial ServicesCommercial Services Curacyte AG develops and markets biopharmaceutical solutions. The firm specializes in the development of new therapeutics for acute and critical care applications. Its focus areas cover applications in hematology, antithrombosism, and oncology. Its pipeline and development portfolio encompasses technologies, such as hemoximers, distributive shock, cardiogenic shock, plasmin and plasma kallikrei, matriptase, and high-dose interleukin-2 therapy. The company was founded in February 2000 and is headquartered in Munich, Germany. | Commercial Services |
Apex Bioscience, Inc.
Apex Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Apex Bioscience, Inc. develops patented products based upon hemoglobin and nitric oxide technologies. The company was founded by Joseph de Angelo on June 17, 1993 and is headquartered in Chapel Hill, NC. | Commercial Services |
ApoLife, Inc.
ApoLife, Inc. Miscellaneous Commercial ServicesCommercial Services ApoLife, Inc. provides screening and lab services. James S. Kuo has been the CEO of the American company since 2012. | Commercial Services |
- Stock Market
- Insiders
- Joseph de Angelo
